CoreCap Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.55K Sell
188
-35
-16% -$419 ﹤0.01% 2481
2026
Q1
$1.34K Buy
223
+10
+5% +$75 ﹤0.01% 2486
2025
Q4
$1.53K Sell
213
-148
-41% -$1.17K ﹤0.01% 2527
2025
Q3
$3.86K Sell
361
-7
-2% -$69 ﹤0.01% 2230
2025
Q2
$3.57K Buy
368
+134
+57% +$1.38K ﹤0.01% 2191
2025
Q1
$3.48K Sell
234
-17
-7% -$261 ﹤0.01% 2192
2024
Q4
$3.75K Buy
251
+105
+72% +$1.71K ﹤0.01% 2046
2024
Q3
$2.8K Sell
146
-43
-23% -$891 ﹤0.01% 2118
2024
Q2
$3.92K Sell
189
-81
-30% -$1.61K ﹤0.01% 1207
2024
Q1
$5.07K Buy
+270
New +$4.63K ﹤0.01% 1913
2022
Q4
$53.5K Buy
+1,915
New +$49K ﹤0.01% 965
2022
Q3
Sell
-807
Closed -$27K 1572
2022
Q2
$27K Buy
+807
New +$28.3K ﹤0.01% 1142
2022
Q1
Sell
-1,243
Closed -$38K 1568
2021
Q4
$38K Buy
+1,243
New +$40.5K ﹤0.01% 1093

Other funds holding OGN

CoreCap Advisors's OGN Position: Q2 2026 in Review

CoreCap Advisors reduced its Organon & Co (OGN) stake by 16% in Q2 2026, selling an estimated $419 and leaving 188 shares worth $2.55K. The position accounts for ﹤0.01% of the portfolio, ranked #2481.

CoreCap Advisors first reported a position in OGN in Q4 2021 and has held it in 13 quarters since. The position peaked at $53.5K in Q4 2022. 107 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • CoreCap Advisors held 188 shares of Organon & Co worth $2.55K as of Q2 2026.
  • CoreCap Advisors sold 35 Organon & Co shares in Q2 2026, an estimated $419.
  • Organon & Co made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2481 holding.
  • CoreCap Advisors first reported a position in Organon & Co in Q4 2021 and has held it in 13 quarters since.
  • CoreCap Advisors's Organon & Co position peaked at $53.5K in Q4 2022.
  • 107 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.